Infection with Helicobacter pylori and leukocyte response in patients with myocardial infarction

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 19, Issue 4, 2000, Pages 298-300

  Galante, A ^a,b   Pietroiusti, A ^a   Carta, S ^a   Franceschelli, L ^a   Piccolo, P ^a   Mastino, A ^c   Fontana, C ^a   Grelli, S ^a   Bergamaschi, A ^a   Magrini, A ^a   Favalli, C ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Clinica Madonna della Letizia   (Italy)

^c IRCCS S Lucia ^*

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CELL ADHESION MOLECULE; IMMUNOGLOBULIN G ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HEART INFARCTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0034057596     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050479     Document Type: Article

References (13)

1. 1. Mendall MA, Gogging PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. British Heart Journal (1994) 71:437-439
2. 2. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU: Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. British Medical Journal (1997) 314:1317-1318
3. 3. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. British Medical Journal (1996) 312:1061-1065
4. 4. Galante A, Pietroiusti A, Domenici B, Magrini A, Carta S, Colace F, Dell'Uomo L, Cipriani C, Argirò G, Zulli C, Martinelli G: Timing and course of leukocyte aggregation in myocardial infarction. Thrombosis and Haemostasis (1995) 74:1221-1224
5. 5. Engler RL, Schmid-Schönbein GW, Pavelec RS: Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. American Journal of Pathology (1983) 11:98-111
6. 6. Mazzone A, Ricevuti G: Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica (1995) 80:161-175
7. 7. Feldman RA, Decks JJ, Evans SJW: Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. European Journal of Clinical Microbiology & Infectious Diseases (1995) 14:428-433
8. 8. Berliner S, Fishelson Z, Bruhis S, Kaufman H, Pinkhas J, Aronson M: The phenomenon of leukergy: induction and detection of leukocyte aggregation in whole human blood. Journal of Laboratory and Clinical Medicine (1987) 109:575-582
9. 9. Galante A, Pietroiusti A, Carta S, Domenici B: A new method to avoid misinterpretations in the evaluation of the leukergy test. Scandinavian Journal of Clinical and Laboratory Investigation (1992) 52:431-443
10. 10. Torgano G, Cosentini R, Mandelli C, Perondi R, Blasi F, Bertinieri G, Van Tien T, Ceriani G, Tarsia P, Arosio C, Ranzi ML: Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation (1999) 99:1555-1559
11. 11. Grayston JT: Chlamydia in atherosclerosis. Circulation (1993) 87:1408-1409
12. 12. Melnick JL, Axam E, De Bakey ME: Possible role of cytomegalovirus in atherogenesis. JAMA (1990) 263:2204-2207
13. 13. Galante A, Pietroiusti A, Magrini A, Carta S, Franceschelli L, Piccolo P, Pistolese GR, Martelli E, Mastino A, Matteucci C, Grelli S, Favalli C: Leukocyte rheological properties are altered in patients with diffuse atherosclerosis. Thrombosis and Haemostasis (1997) 77:1073-1076